Joan A. Keiser

3.2k total citations
63 papers, 2.4k citations indexed

About

Joan A. Keiser is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Joan A. Keiser has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Cardiology and Cardiovascular Medicine and 21 papers in Physiology. Recurrent topics in Joan A. Keiser's work include Nitric Oxide and Endothelin Effects (18 papers), Renin-Angiotensin System Studies (18 papers) and Receptor Mechanisms and Signaling (14 papers). Joan A. Keiser is often cited by papers focused on Nitric Oxide and Endothelin Effects (18 papers), Renin-Angiotensin System Studies (18 papers) and Receptor Mechanisms and Signaling (14 papers). Joan A. Keiser collaborates with scholars based in United States, China and Denmark. Joan A. Keiser's co-authors include He Wang, Stephen J. Haleen, Gilbert H. Mayor, Jianchun Liao, Elwood E. Reynolds, W. E. Scales, Matthew J. Kluger, D G Taylor, Robert L. Panek and Mary Flynn and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American College of Cardiology.

In The Last Decade

Joan A. Keiser

62 papers receiving 2.3k citations

Peers

Countries citing papers authored by Joan A. Keiser

Since Specialization

Citations

This map shows the geographic impact of Joan A. Keiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan A. Keiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan A. Keiser more than expected).

Fields of papers citing papers by Joan A. Keiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan A. Keiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan A. Keiser. The network helps show where Joan A. Keiser may publish in the future.

Co-authorship network of co-authors of Joan A. Keiser

This figure shows the co-authorship network connecting the top 25 collaborators of Joan A. Keiser. A scholar is included among the top collaborators of Joan A. Keiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan A. Keiser. Joan A. Keiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New developments in anthelmintic drugs 2011 ·Tropical Medicine & International Health ·Piero Olliaro, Joan A. Keiser, Annette C. Kuesel, (unknown), J.J. HORTON	1
2	Torcetrapib Induces Aldosterone and Cortisol Production by an Intracellular Calcium-Mediated Mechanism Independently of Cholesteryl Ester Transfer Protein Inhibition 2009 ·Endocrinology ·Xiao Hu, Jessica D. Dietz, Chunsheng Xia, Delvin R. Knight, William Loging, Andrew H. Smith, Haodan Yuan, David A. Perry, Joan A. Keiser	104
3	Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression 2004 ·Biochemical and Biophysical Research Communications ·He Wang, (unknown), Wendy S. Rosebury, Dongkai Wang, Andrew Robertson, Joan A. Keiser	30
4	Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy 2000 ·Journal of the American College of Cardiology ·Ran Kornowski, Martin B. Leon, Shmuel Fuchs, Yoram Vodovotz, Michael A. Flynn, David A. Gordon, Anthony Pierre, Imre Kovesdi, Joan A. Keiser, Stephen E. Epstein	105
5	Hepatocyte Growth Factor Enhances MMP Activity in Human Endothelial Cells 2000 ·Biochemical and Biophysical Research Communications ·He Wang, Joan A. Keiser	60
6	PD 142893, SB 209670, and BQ 788 Selectively Antagonize Vascular Endothelial Versus Vascular Smooth Muscle ETB-Receptor Activity in the Rat 1998 ·Journal of Cardiovascular Pharmacology ·Richard L. Schroeder, Joan A. Keiser, Xue‐Min Cheng, Stephen J. Haleen	3
7	Efficacy of CI-1020, an Endothelin-A Receptor Antagonist, in Hypoxic Pulmonary Hypertension 1998 ·Journal of Cardiovascular Pharmacology ·Stephen J. Haleen, Richard L. Schroeder, (unknown), (unknown), Kathleen M. Welch, Hussein Hallak, Andrew C. G. Uprichard, Joan A. Keiser	15
8	Vascular remodeling in balloon injured rabbit iliac arteries 1998 ·Basic Research in Cardiology ·(unknown), (unknown), Joan A. Keiser	10
9	Influence of lipoprotein(a) plasma concentration on neointimal growth in a monkey model of vascular injury 1998 ·Atherosclerosis ·Michael J. Ryan, (unknown), (unknown), (unknown), David W. Brammer, David Gordon, Bruce J. Auerbach, Joan A. Keiser	2
10	Restenosis: Is There a Pharmacologic Fix in the Pipeline? 1997 ·Advances in pharmacology ·Joan A. Keiser, Andrew C. G. Uprichard	3
11	Evaluation of Physicochemical Parameters Important to the Oral Bioavailability of Peptide-like Compounds: Implications for the Synthesis of Renin Inhibitors 1995 ·Journal of Medicinal Chemistry ·Harriet W. Hamilton, Bruce A. Steinbaugh, Barbra H. Stewart, O. Helen Chan, (unknown), Richard L. Schroeder, Michael J. Ryan, Joan A. Keiser, Michael D. Taylor	24
12	Cardiac Hypertrophy in Rats After Intravenous Administration of CI-959, a Novel Antiinflammatory Compound 1995 ·Journal of Cardiovascular Pharmacology ·(unknown), Alan Metz, (unknown), Scott P. Henry, (unknown), Gordon Loewen, (unknown), D. G. Robertson, (unknown), Richard L. Schroeder, Alec W. Gough, Joan A. Keiser, Douglas L. Mann	1
13	Structure-activity studies of phosphorylated peptide inhibitors of the association of phosphatidylinositol 3-kinase with PDGF-β receptor 1995 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Wayne L. Cody, Gina H. Lu, Robert L. Panek, (unknown), Stuart J. Decker, Joan A. Keiser, Annette M. Doherty	6
14	Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·Michael J. Ryan, (unknown), Brian L. Batley, S. T. Rapundalo, William C. Patt, D G Taylor, Joan A. Keiser	8
15	Effects of selective endothelin antagonists on the hemodynamic response to cyclosporin A. 1994 ·Journal of the American Society of Nephrology ·(unknown), Stephen J. Haleen, Anne M. Doherty, Wayne L. Cody, Joan A. Keiser	22
16	Why Big Endothelin-1 Lacks a Vasodilator Response 1993 ·Journal of Cardiovascular Pharmacology ·Stephen J. Haleen, (unknown), (unknown), Joan A. Keiser	12
17	In Vitro and In Vivo Studies with a Series of Hexapeptide Endothelin Antagonists 1993 ·Journal of Cardiovascular Pharmacology ·Annette M. Doherty, Wayne L. Cody, (unknown), (unknown), (unknown), Kathleen M. Welch, (unknown), Elwood E. Reynolds, (unknown), (unknown), Joan A. Keiser, Stephen J. Haleen	54
18	Thiophene systems. 9. Thienopyrimidinedione derivatives as potential antihypertensive agents 1988 ·Journal of Medicinal Chemistry ·Ronald K. Russell, Jeffery B. Press, Richard Rampulla, James J. McNally, Robert Falotico, Joan A. Keiser, David Bright, Alfonso J. Tobia	147
19	Hepatic extraction of renin: Quantitation and characterization in the isolated perfused rat liver 1987 ·Hepatology ·Joan A. Keiser, J. Carlos Romero, Louis J. Kost, Nicholas F. LaRusso	11
20	Clearance of renin in unanesthetized rats: Effects of chronic lead exposure 1983 ·Toxicology and Applied Pharmacology ·Joan A. Keiser, Arthur J. Vander, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact